X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (749) 749
Publication (56) 56
Book / eBook (37) 37
Book Review (26) 26
Newspaper Article (22) 22
Book Chapter (9) 9
Conference Proceeding (1) 1
Government Document (1) 1
Magazine Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (684) 684
index medicus (354) 354
female (346) 346
male (297) 297
adrenal cortex hormones - therapeutic use (290) 290
middle aged (218) 218
adult (204) 204
aged (155) 155
oncology (135) 135
cancer (131) 131
adrenal cortex hormones - administration & dosage (108) 108
animals (106) 106
adrenal cortex hormones - adverse effects (102) 102
surgery (101) 101
risk factors (95) 95
treatment outcome (95) 95
tumors (86) 86
corticosteroids (84) 84
retrospective studies (84) 84
medicine & public health (76) 76
endocrinology & metabolism (75) 75
adolescent (70) 70
child (70) 70
care and treatment (69) 69
adrenal glands (63) 63
immunosuppressive agents - therapeutic use (61) 61
therapy (59) 59
health aspects (54) 54
diagnosis (52) 52
aged, 80 and over (51) 51
chemotherapy (51) 51
prognosis (51) 51
transplantation (49) 49
antineoplastic agents - adverse effects (48) 48
medicine, general & internal (47) 47
drug therapy, combination (45) 45
follow-up studies (45) 45
management (45) 45
research (44) 44
time factors (43) 43
adrenalectomy (42) 42
immunology (42) 42
child, preschool (41) 41
adrenal cortex neoplasms - surgery (40) 40
hematology (40) 40
young adult (40) 40
mice (39) 39
rats (39) 39
abridged index medicus (38) 38
antineoplastic agents - therapeutic use (38) 38
combined modality therapy (37) 37
neoplasms - complications (37) 37
neoplasms - drug therapy (37) 37
disease (36) 36
incidence (36) 36
carcinoma (35) 35
drug therapy (35) 35
internal medicine (35) 35
analysis (34) 34
diagnosis, differential (34) 34
prevention (33) 33
adrenal cortex (31) 31
immunosuppressive agents - adverse effects (31) 31
infant (31) 31
adrenal cortex neoplasms - pathology (30) 30
adrenal gland neoplasms - surgery (30) 30
children (30) 30
dose-response relationship, drug (30) 30
medicine (30) 30
mortality (30) 30
mutation (30) 30
pharmacology & pharmacy (29) 29
adrenal cortex neoplasms - drug therapy (28) 28
prospective studies (28) 28
adrenal cortex hormones (27) 27
article (27) 27
complications and side effects (27) 27
patients (27) 27
pediatrics (27) 27
respiratory system (27) 27
risk (26) 26
severity of illness index (26) 26
dermatology (25) 25
gastroenterology & hepatology (25) 25
recurrence (25) 25
adrenal cortex neoplasms - genetics (24) 24
antibodies, monoclonal - therapeutic use (24) 24
clinical neurology (24) 24
pheochromocytoma (24) 24
pregnancy (24) 24
prevalence (24) 24
radiotherapy (24) 24
risk-factors (24) 24
adrenalectomy - methods (23) 23
breast-cancer (23) 23
metastasis (23) 23
quality of life (23) 23
steroids (23) 23
survival analysis (23) 23
acute disease (22) 22
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (754) 754
German (20) 20
French (14) 14
Spanish (9) 9
Japanese (6) 6
Italian (5) 5
Russian (4) 4
Hungarian (2) 2
Polish (2) 2
Finnish (1) 1
Portuguese (1) 1
Swedish (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


European Journal of Endocrinology, ISSN 0804-4643, 09/2013, Volume 169, Issue 3, pp. 263 - 270
Journal Article
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2011, Volume 80, Issue 5, pp. 1477 - 1484
Purpose To evaluate the impact of both adjuvant and definitive radiotherapy on local control of adrenocortical carcinoma. Methods and Materials Outcomes were... 
Radiology | Hematology, Oncology and Palliative Medicine | Adrenal glands | Radiotherapy | Radiation oncology | Adrenocortical carcinoma | Adrenal cortex | SURVIVAL | MITOTANE | SERIES | CLINICAL-FEATURES | CANCER | RADIATION-THERAPY | ONCOLOGY | FRENCH-ASSOCIATION | RECURRENCE | EXPERIENCE | ADRENAL-CORTICAL CARCINOMA | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Radiotherapy Dosage | Neoplasm Recurrence, Local - prevention & control | Adrenocortical Carcinoma - secondary | Humans | Middle Aged | Proportional Hazards Models | Male | Treatment Outcome | Adrenal Cortex Neoplasms - pathology | Cancer Care Facilities | Adrenocortical Carcinoma - therapy | Michigan | Adrenal Cortex Neoplasms - therapy | Neoplasm Recurrence, Local - pathology | Adrenocortical Carcinoma - pathology | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Adrenocortical Carcinoma - radiotherapy | Adrenal Cortex Neoplasms - radiotherapy | Female | Adrenocortical Carcinoma - mortality | Combined Modality Therapy - methods | Retrospective Studies | Radiotherapy, Adjuvant | Adrenal Cortex Neoplasms - mortality | Carcinoma | Cancer | SURGERY | NEOPLASMS | MEDICINE | NUCLEAR MEDICINE | ORGANS | DISEASES | THERAPY | GLANDS | CARCINOMAS | ENDOCRINE GLANDS | RADIOLOGY AND NUCLEAR MEDICINE | RADIOTHERAPY | BODY | ADRENAL GLANDS | RADIOLOGY | HAZARDS
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 06/2007, Volume 356, Issue 23, pp. 2372 - 2380
Journal Article
Liver Transplantation, ISSN 1527-6465, 05/2008, Volume 14, Issue 5, pp. 633 - 638
Experience with sirolimus (SRL)‐based immunosuppression following orthotopic liver transplantation (OLT) is rapidly accumulating. In combination with... 
SURGERY | EXPERIENCE | GASTROENTEROLOGY & HEPATOLOGY | CYCLOSPORINE | TRANSPLANTATION | Carcinoma, Hepatocellular - mortality | Liver Failure - mortality | Liver Failure - drug therapy | Liver Transplantation - adverse effects | Humans | Immunosuppressive Agents - therapeutic use | Middle Aged | Liver Failure - pathology | Liver Neoplasms - complications | Male | Adrenal Cortex Hormones - therapeutic use | Liver Neoplasms - mortality | Neoplasm Recurrence, Local - mortality | Calcineurin Inhibitors | Carcinoma, Hepatocellular - drug therapy | Carcinoma, Hepatocellular - complications | Time Factors | Graft Rejection - mortality | Kidney Diseases - chemically induced | Female | Liver Neoplasms - pathology | Retrospective Studies | Drug Therapy, Combination | Sirolimus - adverse effects | Liver Failure - complications | Sirolimus - therapeutic use | Neoplasm Recurrence, Local - prevention & control | Risk Assessment | Graft Rejection - prevention & control | Kaplan-Meier Estimate | Liver Neoplasms - drug therapy | Proportional Hazards Models | Carcinoma, Hepatocellular - surgery | Liver Neoplasms - surgery | Treatment Outcome | Cyclosporine - therapeutic use | Tacrolimus - therapeutic use | Mycophenolic Acid - analogs & derivatives | Mycophenolic Acid - therapeutic use | Carcinoma, Hepatocellular - pathology | Immunosuppressive Agents - adverse effects | Liver Failure - surgery | Index Medicus | Corticoids | Creatinine | Explants | Liver diseases | Renal function | Data processing | Hepatocellular carcinoma | Malignancy | Survival | Immunosuppressive agents | Graft rejection | calcineurin inhibitors | Cirrhosis | Immunosuppression | Ischemia | sirolimus | Mycophenolate mofetil | Age | Liver transplantation | Tumors
Journal Article
International Journal of Hematology, ISSN 0925-5710, 5/2011, Volume 93, Issue 5, pp. 586 - 593
Alemtuzumab is a humanized monoclonal antibody against the CD52 antigen, which is expressed on the surface of various hematopoietic cells such as B and T... 
Chronic graft-versus-host disease | Medicine & Public Health | Hematology | Acute graft-versus-host disease | Oncology | Campath-1H | Alemtuzumab | Allogeneic stem cell transplantation | IN-VIVO ALEMTUZUMAB | DEPLETION | CYTOMEGALOVIRUS-INFECTION | ALLOGENEIC TRANSPLANTATION | PHARMACOKINETICS | LYMPHOCYTE ANTIBODY | CAMPATH | STEM-CELL TRANSPLANTATION | HEMATOLOGY | ADOPTIVE IMMUNOTHERAPY | T-CELLS | Graft vs Host Disease - therapy | Hematologic Neoplasms - therapy | Antigens, CD - immunology | Recurrence | Humans | Glycoproteins - metabolism | Opportunistic Infections - prevention & control | Graft vs Host Disease - immunology | Transplantation, Homologous | Antigens, CD - metabolism | Antibodies, Monoclonal, Humanized | Antibodies, Neoplasm - metabolism | Drug Dosage Calculations | Graft vs Host Disease - mortality | T-Lymphocytes - drug effects | Antigens, Neoplasm - metabolism | Killer Cells, Natural - immunology | B-Lymphocytes - pathology | Lymphocyte Transfusion | T-Lymphocytes - pathology | CD52 Antigen | Drug Administration Routes | Drug Administration Schedule | Antigens, Neoplasm - immunology | Antibodies, Monoclonal - pharmacokinetics | Hematopoietic Stem Cell Transplantation | Clinical Trials as Topic | Antibodies, Neoplasm - administration & dosage | Adrenal Cortex Hormones - adverse effects | B-Lymphocytes - drug effects | Glycoproteins - immunology | B-Lymphocytes - immunology | Antibodies, Monoclonal - administration & dosage | Graft vs Host Disease - physiopathology | Survival Analysis | Graft vs Host Disease - prevention & control | T-Lymphocytes - immunology | Antibodies, Monoclonal - metabolism | Hematologic Neoplasms - immunology | Transplantation Conditioning | Adrenal Cortex Hormones - administration & dosage | Antigens | Care and treatment | Antibodies | Transplantation | Antineoplastic agents | T cells | Virus diseases | Prevention | Viral antibodies | Antimitotic agents | Stem cells | Bone marrow | Monoclonal antibodies
Journal Article
Journal Article
Journal Article
Journal Article